FLSM

Frazier Life Sciences Management Portfolio holdings

AUM $3.34B
1-Year Est. Return 92.56%
This Quarter Est. Return
1 Year Est. Return
+92.56%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.38B
AUM Growth
-$227M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
52
New
Increased
Reduced
Closed

Top Buys

1
+$19.4M
2
+$18.5M
3
+$18.2M
4
MGNX icon
MacroGenics
MGNX
+$12.2M
5
MORF
Morphic Holding, Inc. Common Stock
MORF
+$8.06M

Top Sells

1
+$143M
2
+$16.4M
3
+$4.35M
4
REPL icon
Replimune Group
REPL
+$4.32M
5
EPIX
ESSA Pharma
EPIX
+$1.52M

Sector Composition

1 Healthcare 99.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$12.3M 0.89%
6,663,590
27
$12.2M 0.88%
+1,703,204
28
$12.1M 0.88%
686,762
-244,798
29
$11.6M 0.84%
1,352,199
+18,799
30
$9.59M 0.69%
393,000
31
$9.09M 0.66%
585,759
32
$8.21M 0.59%
1,776,479
33
$8.06M 0.58%
+214,240
34
$7.8M 0.56%
285,331
35
$7.67M 0.56%
500,000
36
$7.59M 0.55%
203,684
37
$6.89M 0.5%
3,746,857
38
$6.82M 0.49%
+9,660
39
$6.2M 0.45%
127,900
40
$5.51M 0.4%
610,000
41
$5.46M 0.4%
881,173
42
$4.95M 0.36%
1,112,684
-3,679,316
43
$4.58M 0.33%
72,038
44
$4.55M 0.33%
+682,461
45
$3.6M 0.26%
187,846
46
$3.21M 0.23%
+1,647,030
47
$2.14M 0.15%
264,377
-25,812
48
$921K 0.07%
500,333
49
$29.7K ﹤0.01%
17,025
50
– –
-605,141
1
2
3